Cellomics International Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Cellomics International General Information

Description

Operator of the biotech company focusing on the development of biopsy products and services intended for the treatment of cancer. The company offers services such as cutting edge technology, companion diagnosis, sorting platform and real-time monitoring, helping doctors and patients in the management and early detection of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Block A, Langwei Village, Number 16 Baoshan Road, Liulian Community
  • Pingshan Subdistrict Office, Pingshan District
  • Shenzhen, Guangdong 518118
  • China
+86 0755
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 2nd Floor, Block A, Langwei Village, Number 16 Baoshan Road, Liulian Community
  • Pingshan Subdistrict Office, Pingshan District
  • Shenzhen, Guangdong 518118
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellomics International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Oct-2024 Completed Generating Revenue
5. Later Stage VC 09-Nov-2023 Completed Generating Revenue
4. Later Stage VC (Series B1) 03-Jul-2023 Completed Generating Revenue
3. Later Stage VC 01-Mar-2022 Completed Generating Revenue
2. Later Stage VC (Series B) 24-Sep-2021 Completed Generating Revenue
1. Accelerator/Incubator 22-Apr-2019 Completed Generating Revenue
To view Cellomics International’s complete valuation and funding history, request access »

Cellomics International Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellomics International Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hong Kong Science & Technology Parks Accelerator/Incubator Minority
China Taiping Insurance Investment Corporate Venture Capital Minority
Beyond Ventures Venture Capital Minority
Jacobson Pharma Corporation Minority
Raffles Family Office Family Office Minority
You’re viewing 5 of 7 investors. Get the full list »

Cellomics International FAQs

  • When was Cellomics International founded?

    Cellomics International was founded in 2018.

  • Where is Cellomics International headquartered?

    Cellomics International is headquartered in Shenzhen, China.

  • What is the size of Cellomics International?

    Cellomics International has 32 total employees.

  • What industry is Cellomics International in?

    Cellomics International’s primary industry is Diagnostic Equipment.

  • Is Cellomics International a private or public company?

    Cellomics International is a Private company.

  • What is Cellomics International’s current revenue?

    The current revenue for Cellomics International is .

  • Who are Cellomics International’s investors?

    Hong Kong Science & Technology Parks, China Taiping Insurance Investment, Beyond Ventures, Jacobson Pharma, and Raffles Family Office are 5 of 7 investors who have invested in Cellomics International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process